|
⚲
|
| Keyboard |
| Barlow Carrolee
✚
|
|
|---|---|
| CIK # | 0001745316 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001745316] | |
| 4 | [0001745316] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Barlow Carrolee | |
| Supernus Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-24 | Disposed to issuer | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2026-02-24 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2026-02-18 | Grant | 2,989 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2026-02-18 | Grant | 4,977 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2025-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2025-02-22 | Disposed to issuer | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 7,296 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2025-02-19 | Grant | 4,475 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-23 | Disposed to issuer | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-23 | Grant | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-02-22 | Grant | 8,252 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-23 | Grant | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2023-02-23 | Grant | 6,293 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-22 | Disposed to issuer | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-02-22 | Grant | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2022-02-22 | Grant | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2022-02-22 | Grant | 6,847 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2022-02-19 | Grant | 4,222 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2022-02-19 | Disposed to issuer | 4,222 | $0.00 | |
| showing 20 of 26 most recent transactions | |||||